PROTAGENIC THERAPEUTICS INC - COM (PTIX)

CUSIP: 74365N103

Q4 2021 13F Holders as of 31 Dec 2021

Share change
-14,124
SEC-reported price per share
$1.39
Indexed holders
13
Value change
-$49,723
Number of buys
7
Number of sells
5

Security key

74365N103

Report period

Q4 2021

Indexed institutions

13

Top holders

9

Ownership snapshot

Top reported holders of PTIX - PROTAGENIC THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORACLE INVESTMENT MANAGEM...
Disclosed value leader
ORACLE INVESTMENT MANAGEM...
Comparable rows
0/14
Latest evidence
30 Sep 2021
13F Highest disclosed value: $935,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

ORACLE INVESTMENT MANAGEMENT INC has the largest disclosed position value at $935K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORACLE INVESTMENT MANAGEMENT INC's linked filing trail.
Disclosed position value Top 5
ORACLE INVESTMENT MANAGEMENT INC $935K
VANGUARD GROUP INC $246K
GEODE CAPITAL MANAGEMENT, LLC $194K
Warberg Asset Management LLC $143K
MORGAN STANLEY $109K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORACLE INVESTMENT MANAGEMENT INC
13F
Company
13F
—
denominator unverified
$935,000
500,000 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$246,000
131,515 shares
— 30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$194,000
103,879 shares
— 30 Sep 2021
Warberg Asset Management LLC
13F
Company
13F
—
denominator unverified
$143,000
364,791 shares
— 30 Sep 2021
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$109,000
58,058 shares
— 30 Sep 2021
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$102,000
54,400 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
13
Shares
953,552
Indexed holders
13
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 indexed holders
13
Q4 2021 indexed holders
13
Indexed holder difference
0
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .